Skip to content
Plinth
← FundingAlso makes grants — grantmaker profile →

Illinois · Nonprofit

AMERICAN SOCIETY FOR TRANSPLANTATION & CELLULAR THERAPY

AMERICAN SOCIETY FOR TRANSPLANTATION & CELLULAR THERAPY (Illinois) receives grants from 3 organizations whose IRS filings report $70,000 to it, the largest being GABRIELLE'S ANGEL FOUNDATION FOR CANCER RESEARCH INC ($30,000). 0 of them have funded it in more than one year.

$8.5M
Revenue FY2024
3
Funders on record
$70k
Grants received
$9.2M
Net assets
0/3 repeat funderspeak grant-dependency 1%

Against its field

AMERICAN SOCIETY FOR TRANSPLANTATION & CELLULAR THERAPY has grown faster than half of the 8,110 health nonprofits its size.

Operating margin−0% · below the median
Months of reserve2.8mo · below the median
Revenue growth (annualized)11% · above the median

this organization peer median middle 50% of peers· 8,110 health nonprofits $1M–$10M, FY2024

Three funders worth looking at

Grantmakers with no record of funding this organization, ranked by how strongly the co-funder graph and the mission embeddings agree. The evidence is in section 03.

See all 12 prospects and why each one surfaced →
01The organization over time

The organization over time

Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.

100 = 20172017 Revenue 100 ($4.1M) Expenses 100 ($3.9M) Net assets 100 ($4.8M)2019 Revenue 134 ($5.4M) Expenses 112 ($4.4M) Net assets 143 ($6.8M)2020 Revenue 143 ($5.8M) Expenses 113 ($4.4M) Net assets 169 ($8.1M)2021 Revenue 136 ($5.5M) Expenses 123 ($4.8M) Net assets 203 ($9.7M)2022 Revenue 187 ($7.6M) Expenses 176 ($6.9M) Net assets 164 ($7.9M)2023 Revenue 200 ($8.1M) Expenses 213 ($8.3M) Net assets 184 ($8.8M)2024 Revenue 210 ($8.5M) Expenses 218 ($8.5M) Net assets 191 ($9.2M)
2017201920202021202220232024
Revenue (210)Expenses (218)Net assets (191)Peer revenue range

How it's funded, over time

Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.

2017
2019
2020
2021
2022
2023
2024
ContributionsProgram revenueInvestmentOther

33% of AMERICAN SOCIETY FOR TRANSPLANTATION & CELLULAR THERAPY’s revenue is contributions — about as donation-reliant as the typical peer (51% for the typical peer).

This organization
Typical peer · 8,590 orgs

Surplus & reserves

Operating surplus or deficit each year, and months of liquidity in hand. 2 of the last 7 reported years ran a deficit.

$148k
17
$1.1M
19
$1.4M
20
$731k
21
$686k
22
$212k
23
$30k
24
2.8
months of
reserve
02Who funds it

Who funds it, year by year

Grant support over time, funder by funder — shade shows the grant size each year.

From the IRS filings of AMERICAN SOCIETY FOR TRANSPLANTATION & CELLULAR THERAPY’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How concentrated its funding is

AMERICAN SOCIETY FOR TRANSPLANTATION & CELLULAR THERAPY leans on a few funders — its largest provides 43% of grant income and the top three 100%; half comes from just 2 funders.

the vertical line marks half of all grant income — 2 funders to its left

100% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund AMERICAN SOCIETY FOR TRANSPLANTATION & CELLULAR THERAPY.

43%
largest funder
100%
top three
~3
effective funders

“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

Where its funders are

AMERICAN SOCIETY FOR TRANSPLANTATION & CELLULAR THERAPY draws 100% of its grant income from funders outside Illinois, across 3 states in all.

NY
MO
NC

Funder states come from each funder’s own filing. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

03Its place in the field

Funders to approach

Grantmakers that don’t fund you yet, surfaced two ways: they back organizations that share your funders, or their grantees resemble your mission. The ones both signals agree on come first. Your 3 funders put you under-funded among the 400 organizations that share them.

From the co-funder graph (funders backing at least two comparable organizations, shrunk for grantee count, donor-advised and mega-funds excluded) and the universe embeddings. A research starting point; overlap is association, not a guarantee of fit.

Organizations like AMERICAN SOCIETY FOR TRANSPLANTATION & CELLULAR THERAPY

Nonprofits whose mission and program text most resemble this one, by semantic similarity over the universe of US filings — the closest peers, and often the clearest route to shared or prospective funders.

In Illinois

Nationally

04Profile & governance

Read directly from this organization’s own Form 990, as neutral context.

Where the money goes

93% of spending goes to programs.

Program 93%Management 7%Fundraising 0%

Governance

15
board members
93%
independent
Conflict-of-interest policyWhistleblower policyDocument retentionBoard reviewed the 990Audited financials

Public support

80%

Share of support from the public (Schedule A) — the basis for its public-charity status.

Footprint & structure

Files a return copy in 1 state

IL

Screen this organization

A dated, signed PDF of the compliance screen for AMERICAN SOCIETY FOR TRANSPLANTATION & CELLULAR THERAPY: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.

A paid feature, included from the $75 plan up. Sign in to download.

Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. How the screen works · on the API as GET /api/screening/{ein}?format=pdf

Questions and answers

Who funds AMERICAN SOCIETY FOR TRANSPLANTATION & CELLULAR THERAPY?
AMERICAN SOCIETY FOR TRANSPLANTATION & CELLULAR THERAPY (Illinois) receives grants from 3 organizations whose IRS filings report $70,000 to it, the largest being GABRIELLE'S ANGEL FOUNDATION FOR CANCER RESEARCH INC ($30,000). 0 of them have funded it in more than one year.
How many funders does AMERICAN SOCIETY FOR TRANSPLANTATION & CELLULAR THERAPY have?
IRS filings report 3 organizations giving $70,000 in grants to AMERICAN SOCIETY FOR TRANSPLANTATION & CELLULAR THERAPY.
Who is the largest funder of AMERICAN SOCIETY FOR TRANSPLANTATION & CELLULAR THERAPY?
GABRIELLE'S ANGEL FOUNDATION FOR CANCER RESEARCH INC is the largest funder on record, with $30,000 in grants. The full list of funders is on this page.
How can an organization like AMERICAN SOCIETY FOR TRANSPLANTATION & CELLULAR THERAPY find more funders?
Start with the funders already giving here, then look at the foundations that back similar organizations in Illinois. The funding by cause and by state pages list the largest funders for a given area and how to approach them.

These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2024 (financials across 2017–2024), and the filings of 3funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported August 27, 2026. What this page cannot tell you · view filing